COX-2: An in vivo evidence of its participation in heat stress-induced myocardial preconditioning

Cardiovascular Research

Volumn 58, Issue 3, 2003, Pages 582-588

  Arnaud, Claire ^a   Joyeux Faure, Marie ^a   Godin Ribuot, Diane ^a   Ribuot, Christophe ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

Cyclooxygenase 2; Ischemia; Preconditioning; Shock

Indexed keywords

ANESTHETIC AGENT; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TYPE; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEAT STRESS; IN VIVO STUDY; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOTTING, WESTERN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; HEAT; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOENZYMES; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, WISTAR; SULFONAMIDES;

EID: 0038206900     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00295-5     Document Type: Article

References (46)

1. Mestril R., Dillmann W.H. Heat shock proteins and protection against myocardial ischemia. J Mol Cell Cardiol. 27:1995;45-52.
2. Currie R.W., Karmazyn M., Kloc M., Mailer K. Heat-shock response is associated with enhanced postischemic ventricular recovery. Circ Res. 63:1988;543-549.
3. Donnelly T.J., Sievers R.E., Vissern F.L., Welch W.J., Wolfe C.L. Heat shock protein induction in rat hearts. A role for improved myocardial salvage after ischemia and reperfusion? Circulation. 85:1992;769-778.
4. Yellon D.M., Pasini E., Cargnoni A., et al. The protective role of heat stress in the ischaemic and reperfused rabbit myocardium. J Mol Cell Cardiol. 24:1992;895-907.
5. Arnaud C., Laubriet A., Joyeux M., et al. Role of nitric oxide synthases in the infarct size-reducing effect conferred by heat stress in isolated rat hearts. Br J Pharmacol. 132:2001;1845-1851.
6. Arnaud C., Joyeux M., Garrel C., et al. Free-radical production triggered by hyperthermia contributes to heat stress-induced cardioprotection in isolated rat hearts. Br J Pharmacol. 135:2002;1776-1782.
7. Bishop-Bailey D.L.S., Warner T.D., Chen G., Mitchell J.A. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. Br J Pharmacol. 121:1997;125-133.
8. LaPointe M.C., Isenovic E. Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension. 33:1999;276-282.
9. Vane J.R., Bakhle Y.S., Botting R.M. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 38:1998;97-120.
10. Katircioglu S.F., Ulus A.T., Iscan Z., et al. Preservation of myocardial metabolism in acute coronary artery occlusions with retrograde coronary sinus perfusion and iloprost. Prostaglandins Leukot Essent Fatty Acids. 59:1998;169-174.
11. Hide E.J., Thiemermann C. Sulprostone-induced reduction of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels. Br J Pharmacol. 118:1996;1409-1414.
12. Guo Y., Bao W., Wu W.J., et al. Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice. Basic Res Cardiol. 95:2000;479-484.
13. Shinmura K., Tang X.L., Wang Y., et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA. 97:2000;10197-10202.
14. Bolli R. The late phase of preconditioning. Circ Res. 87:2000;972-983.
15. Joyeux M., Godin-Ribuot D., Yellon D.M., Demenge P., Ribuot C. Heat stress response and myocardial protection. Fundam Clin Pharmacol. 13:1999;1-10.
16. Saito T., Rodger I.W., Hu F., Shennib H., Giaid A. Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction. Biochem Biophys Res Commun. 273:2000;772-775.
17. Wong S.C., Fukuchi M., Melnyk P., Rodger I., Giaid A. Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation. 98:1998;100-103.
18. Shinmura K., Nagai M., Tamaki K., Tani M., Bolli R. COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts. Am J Physiol Heart Circ Physiol. 283:2002;H2534-2543.
19. Schmedtje J.F. Jr., Ji Y.S., Liu W.L., DuBois R.N., Runge M.S. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem. 272:1997;601-608.
20. Adderley S.R., Fitzgerald D.J. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J Biol Chem. 274:1999;5038-5046.
21. LaPointe M.C., Sitkins J.R. Phospholipase A2 metabolites regulate inducible nitric oxide synthase in myocytes. Hypertension. 31:1998;218-224.
22. Shinmura K., Xuan Y.T., Tang X.L., et al. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res. 90:2002;602-608.
23. Nakamura T., Sakamoto K. Reactive oxygen species up-regulates cyclooxygenase-2, p53, and Bax mRNA expression in bovine luteal cells. Biochem Biophys Res Commun. 284:2001;203-210.
24. von Knethen A., Callsen D., Brune B. Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression. J Immunol. 163:1999;2858-2866.
25. Feng L., Xia Y., Garcia G.E., Hwang D., Wilson C.B. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. J Clin Invest. 95:1995;1669-1675.
26. Pang L., Nie M., Corbett L., et al. Protein kinase C-epsilon mediates bradykinin-induced cyclooxygenase-2 expression in human airway smooth muscle cells. Faseb J. 16:2002;1435-1447.
27. Giroux M., Descoteaux A. Cyclooxygenase-2 expression in macrophages: modulation by protein kinase C-alpha. J Immunol. 165:2000;3985-3991.
28. Yamamoto K., Arakawa T., Ueda N., Yamamoto S. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem. 270:1995;31315-31320.
29. Joyeux M., Baxter G.F., Thomas D.L., Ribuot C., Yellon D.M. Protein kinase C is involved in resistance to myocardial infarction induced by heat stress. J Mol Cell Cardiol. 29:1997;3311-3319.
30. Joyeux M., Boumendjel A., Carroll R., et al. SB 203580, a mitogen-activated protein kinase inhibitor, abolishes resistance to myocardial infarction induced by heat stress. Cardiovasc Drugs Ther. 14:2000;337-343.
31. Yamashita N., Hoshida S., Otsu K., et al. Involvement of cytokines in the mechanism of whole-body hyperthermia-induced cardioprotection. Circulation. 102:2000;452-457.
32. Beg A.A., Finco T.S., Nantermet P.V., Baldwin A.S. Jr. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol. 13:1993;3301-3310.
33. Chandrasekar B., Streitman J.E., Colston J.T., Freeman G.L. Inhibition of nuclear factor kappa B attenuates proinflammatory cytokine and inducible nitric-oxide synthase expression in postischemic myocardium. Biochim Biophys Acta. 1406:1998;91-106.
34. Yang C.M., Chien C.S., Hsiao L.D., Luo S.F., Wang C.C. Interleukin-1beta-induced cyclooxygenase-2 expression is mediated through activation of p42/44 and p38 MAPKS, and NF-kappaB pathways in canine tracheal smooth muscle cells. Cell Signal. 14:2002;899-911.
35. Molina-Holgado E., Ortiz S., Molina-Holgado F., Guaza C. Induction of COX-2 and PGE(2) biosynthesis by IL-1beta is mediated by PKC and mitogen-activated protein kinases in murine astrocytes. Br J Pharmacol. 131:2000;152-159.
36. Arad M., Oxman T., Leor R., Rabinowitz B. Prostaglandins and the antiarrhythmic effect of preconditioning in the isolated rat heart. Mol Cell Biochem. 160-161:1996;249-255.
37. Joyeux M., Bouchard J.F., Lamontagne D., Godin-Ribuot D., Ribuot C. Heat stress-induced protection of endothelial function against ischaemic injury is abolished by ATP-sensitive potassium channel blockade in the isolated rat heart. Br J Pharmacol. 130:2000;345-350.
38. Calderwood S.K., Bornstein B., Farnum E.K., Stevenson M.A. Heat shock stimulates the release of arachidonic acid and the synthesis of prostaglandins and leukotriene B4 in mammalian cells. J Cell Physiol. 141:1989;325-333.
39. Salzman J., Bowman P.D. Independent regulation of prostaglandin production and the stress response in human fibroblasts. J Cell Physiol. 152:1992;626-631.
40. Bouchard J.F., Dumont E., Lamontagne D. Evidence that prostaglandins I2, E2, and D2 may activate ATP sensitive potassium channels in the isolated rat heart. Cardiovasc Res. 28:1994;901-905.
41. Nakhostine N., Lamontagne D. Contribution of prostaglandins in hypoxia-induced vasodilation in isolated rabbit hearts. Relation to adenosine and KATP channels. Pfluger's Arch. 428:1994;526-532.
42. Hide E.J., Ney P., Piper J., Thiemermann C., Vane J.R. Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels. Br J Pharmacol. 116:1995;2435-2440.
43. Pell T.J., Yellon D.M., Goodwin R.W., Baxter G.F. Myocardial ischemic tolerance following heat stress is abolished by ATP-sensitive potassium channel blockade. Cardiovasc Drugs Ther. 11:1997;679-686.
44. Hoag J.B., Qian Y.Z., Nayeem M.A., D'Angelo M., Kukreja R.C. ATP-sensitive potassium channel mediates delayed ischemic protection by heat stress in rabbit heart. Am J Physiol. 273:1997;H2458-2464.
45. Joyeux M., Godin-Ribuot D., Ribuot C. Resistance to myocardial infarction induced by heat stress and the effect of ATP-sensitive potassium channel blockade in the rat isolated heart. Br J Pharmacol. 123:1998;1085-1088.
46. Ozcan C., Bienengraeber M., Dzeja P.P., Terzic A. Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am J Physiol Heart Circ Physiol. 282:2002;H531-539.